News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Secures a Discovery Milestone Payment from Gemin X Biotechnologies Inc.



8/7/2007 11:17:55 AM

RICHMOND, Va. & MONTREAL & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research (TDR) Limited, a wholly owned subsidiary within the Commonwealth Biotechnologies, Inc. (CBI) group of companies (NASDAQ Capital Market:CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has secured a milestone payment from Gemin X Biotechnologies Inc., a biopharmaceutical company specializing in the discovery and development of novel small molecule cancer therapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES